glp-1 alcohol Therapeutics and Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer GLP-1 medications: The next big
Description
doi: 10.1002/jnr.23335 220 GaoCLiuYJiangYDingJLiL

[PubMed Central ID: PMC8660013]

More research is needed to support these results [47]

There is increasing evidence for, and interest in, the concept of 'diabetes remission' using intensive lifestyle interventions early after diagnosis

In the weeks after the FDA's announcement, health care providers and patient groups have pressed the country's top workplaces for women, including Nike, Hilton and Comcast NBCUniversal, to cover comprehensive obesity care for workers
Unlike some medications that peak and fade within hours, GLP-1 drugs have a long half-life. A half-life is the time it takes for the concentration of a drug in your body to reduce by half